These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34294687)

  • 1. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer.
    Zhong C; Wu K; Wang S; Long Z; Yang T; Zhong W; Tan X; Wang Z; Li C; Lu J; Mao X
    Cell Death Dis; 2021 Jul; 12(8):726. PubMed ID: 34294687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Zhang Z; Mou Z; Xu C; Wu S; Dai X; Chen X; Ou Y; Chen Y; Yang C; Jiang H
    Cell Death Dis; 2021 Aug; 12(8):778. PubMed ID: 34365465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0006220 (circ-TADA2A) accelerates prostate cancer cell malignant behaviors through miR-520f-3p/CDCA7 axis.
    Wan Z; Liu G
    Cell Mol Biol (Noisy-le-grand); 2024 Jul; 70(7):85-91. PubMed ID: 39097891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis.
    Wang P; Zhang L; Yin S; Xu Y; Tai S; Zhang LI; Liang C
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):815-822. PubMed ID: 33978716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
    Liu B; Li X; Li J; Jin H; Jia H; Ge X
    Dis Markers; 2020; 2020():8860788. PubMed ID: 33101546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_Circ_0001206 is downregulated and inhibits cell proliferation, migration and invasion in prostate cancer.
    Song Z; Zhuo Z; Ma Z; Hou C; Chen G; Xu G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2449-2464. PubMed ID: 31198063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
    Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
    Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
    Xing Q; Liu S; Luan J; Wang Y; Ma L
    Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer.
    Shao N; Zhu Y; Wan FN; Ye DW
    Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer.
    Hu Y; Guo B
    J Clin Lab Anal; 2020 Mar; 34(3):e23086. PubMed ID: 31713278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients.
    Avgeris M; Stravodimos K; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1095-104. PubMed ID: 25153390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
    Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
    Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation.
    Yan L; Liu G; Cao H; Zhang H; Shao F
    Biochem Biophys Res Commun; 2019 Oct; 519(1):172-178. PubMed ID: 31492499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
    Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
    BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.